Does ORITAVANCIN Cause Infusion site extravasation? 17 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Infusion site extravasation have been filed in association with ORITAVANCIN (Orbactiv). This represents 1.9% of all adverse event reports for ORITAVANCIN.
17
Reports of Infusion site extravasation with ORITAVANCIN
1.9%
of all ORITAVANCIN reports
0
Deaths
2
Hospitalizations
How Dangerous Is Infusion site extravasation From ORITAVANCIN?
Of the 17 reports, 2 (11.8%) required hospitalization.
Is Infusion site extravasation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ORITAVANCIN. However, 17 reports have been filed with the FAERS database.
What Other Side Effects Does ORITAVANCIN Cause?
Off label use (174)
Pruritus (163)
Urticaria (106)
Back pain (85)
Rash (84)
Chills (82)
Dyspnoea (72)
Nausea (66)
Infusion related reaction (62)
Erythema (59)
What Other Drugs Cause Infusion site extravasation?
HUMAN IMMUNOGLOBULIN G (822)
INFLIXIMAB (435)
INFLIXIMAB-DYYB (328)
TREPROSTINIL (256)
VEDOLIZUMAB (199)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN (185)
REMDESIVIR (144)
FERRIC CARBOXYMALTOSE (118)
RITUXIMAB (82)
NATALIZUMAB (70)
Which ORITAVANCIN Alternatives Have Lower Infusion site extravasation Risk?
ORITAVANCIN vs ORITAVANCIN DIPHOSPHATE
ORITAVANCIN vs ORLISTAT
ORITAVANCIN vs ORNIDAZOLE
ORITAVANCIN vs ORPHENADRINE
ORITAVANCIN vs OSELTAMIVIR